Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3-/- mice

Oncogene

Volumn 25, Issue 49, 2006, Pages 6489-6496

  Cruz Munoz, W ^a   Sanchez, O H ^b   Di Grappa, M ^a   English, J L ^a   Hill, R P ^a   Khokha, R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY   (Canada)

Author keywords

Deficient mice; Lymphoma; Melanoma; Metastasis; TIMP 3

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BONE METASTASIS; CANCER INFILTRATION; CANCER INVASION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPATHOLOGY; ENZYME ACTIVATION; GENOTYPE; KIDNEY METASTASIS; KNOCKOUT MOUSE; LIVER METASTASIS; LUNG BLOOD VESSEL; LUNG METASTASIS; LYMPHOMA CELL; MACROPHAGE; MELANOMA CELL; MOUSE; NEUTROPHIL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR VASCULARIZATION;

ANIMALS; CELL PROLIFERATION; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; KIDNEY; KIDNEY NEOPLASMS; LUNG; LUNG NEOPLASMS; LYMPHOMA; MATRIX METALLOPROTEINASE 2; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 33750204176     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209663     Document Type: Article

References (39)

1. Ahonen M, Baker AH, Kahari VM. (1998). Cancer Res 58: 2310-2315.
2. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL et al. (1999). Br J Cancer 80: 733-743.
3. Banerji A, Chakrabarti J, Mitra A, Chatterjee A. (2004). Cancer Lett 211: 235-242.
4. Cameron MD, Schmidt EE, Kerkvliet N, Nadkarni KV, Morris VL, Groom AC et al. (2000). Cancer Res 60: 2541-2546.
5. Castells A, Rustgi AK. (2003). Tumour growth, invasion and metastasis. In Rustgi AK (ed). Gastrointestinal Cancers: A Companion To Sleisenger & Fordtran's GI And Liver Disease. WB Saunders: New York, pp 69-79.
6. Chang C, Werb Z. (2001). Trends Cell Biol 11: S37-S43.
7. Coussens LM, Werb Z. (2002). Nature 420: 860-867.
8. Cruz-Munoz W, Kim I, Khokha R. (2006). Oncogene 25: 650-655.
9. De Larco JE, Wuertz BR, Gurcht LT. (2004). Clin Cancer Res 10: 4895-4900.
10. Ding L, Sunamura M, Kodama T, Yamauchi J, Duda DG, Shimamura H et al. (2001). Br J Cancer 85: 431-438.
11. English JL, Kassiri Z, Koskivirta I, Atkinson SJ, Di Grappa M, Soloway PD et al. (2006). J Biol Chem 281: 10337-10346.
12. Gill SE, Pape MC, Khokha R, Watson AJ, Leco KJ. (2003). Dev Biol 261: 313-323.
13. Hofmann UB, Eggert AA, Blass K, Brocker EB, Becker JC. (2005). Arch Dermatol Res 297: 154-160.
14. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN. (2000). J Pathol 191: 245-256.
15. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. (1998). Cancer Res 58: 1048-1051.
16. Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK et al. (2005). Circ Res 97: 380-390.
17. Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S, Brodt P. (1999). Cancer Res 59: 1356-1361.
18. Kitakata H, Nemoto-Sasaki Y, Takahashi Y, Kondo T, Mai M, Mukaida N. (2002). Cancer Res 62: 6682-6687.
19. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. (1994). J Biol Chem 269: 9352-9360.
20. Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A et al. (2001). J Clin Invest 108: 817-829.
21. Lin EY, Nguyen AV, Russell RG, Pollard JW. (2001). J Exp Med 193: 727-740.
22. Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J et al. (1999). J Biol Chem 274: 13613-13618.
23. Miyazaki T, Kato H, Nakajima M, Faried A, Takita J, Sohda M et al. (2004). Br J Cancer 91: 1556-1560.
24. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH et al. (2004). Nat Genet 36: 969-977.
25. Mundy GR. (2002). Nat Rev Cancer 2: 584-593.
26. Nuttall RK, Sampieri CL, Pennington CJ, Gill SE, Schultz GA, Edwards DR. (2004). FEBS Lett 563: 129-134.
27. Orr FW, Kostenuik P, Sanchez-Sweatman OH, Singh G. (1993). Breast Cancer Res Treat 25: 151-163.
28. Pastorino U, Andreola S, Tagliabue E, Pezzella F, Incarbone M, Sozzi G et al. (1997). J Clin Oncol 15: 2858-2865.
29. Perez M, Migliaccio S, Taranta A, Festuccia C, Orru L, Brama M et al. (2001). Eur J Cancer 37: 629-640.
30. Powe DG, Brough JL, Carter GI, Bailey EM, Stetler-Stevenson WG, Turner DR et al. (1997). Br J Cancer 75: 1678-1683.
31. Salmela MT, Karjalainen-Lindsberg ML, Jeskanen L, Saarialho-Kere U. (2003). Mod Pathol 16: 108-114.
32. Sanchez-Sweatman OH, Lee J, Orr FW, Singh G. (1997). Eur J Cancer 33: 918-925.
33. Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG et al. (2001). J Cell Physiol 189: 197-206.
34. Soloway PD, Alexander CM, Werb Z, Jaenisch R. (1996). Oncogene 13: 2307-2314.
35. Spurbeck WW, Ng CY, Strom TS, Vanin EF, Davidoff AM. (2002). Blood 100: 3361-3368.
36. Urban BA, Fishman EK. (2000). Radiographics 20: 197-212.
37. Woessner Jr JF. (2001). J Clin Invest 108: 799-800.
38. Yu WH, Yu S, Meng Q, Brew K, Woessner Jr JF. (2000). J Biol Chem 275: 31226-31232.
39. Zhang L, Hill RP. (2004). Cancer Res 64: 4180-4189.